| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Daniel D. Long | SVP, Drug Discovery | Oct 24, 2024 | |||
| Jeffrey K. Tong | Director | Oct 24, 2024 | |||
| Uwe Klein | SVP, Biological Sciences | Oct 24, 2024 | |||
| Jae B. Kim | Chief Medical Officer | Oct 24, 2024 | |||
| Abraham Bassan | Director | Oct 24, 2024 | |||
| Ran Xiao | Interim CFO | Oct 24, 2024 | |||
| Bernard Coulie | Director | Oct 24, 2024 | |||
| Elizabeth Bhatt | Chief Operating Officer | Oct 24, 2024 | |||
| Jake Simson | Director | Oct 24, 2024 | |||
| Shalini Sharp | Director | Oct 24, 2024 | |||
| Alan Ezekowitz | Director | Oct 24, 2024 | |||
| Jeffrey Finer | CEO and President, Director | Oct 24, 2024 | |||
| Ra Capital Management, L.P. | Director, 10%+ Owner | Oct 28, 2024 | |||
| Third Rock Ventures V, L.P. | 10%+ Owner | Oct 28, 2024 | |||
| Samira Shaikhly | Chief People Officer | Oct 24, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|